Jana L.
- Country
- Slovakia
- Department
- Kardiologicka ambulancia
Research Overview
Data & Insights
Has run more than one trial at 0 of 368 partner sites.
Specializations
Primary Prevention of Cardiovascular Events
Focuses on adults at elevated risk of coronary heart disease, myocardial infarction and ischemic stroke who have not experienced prior events.
- Risk assessment in asymptomatic high‑risk adults
- Integration of lipid‑lowering strategies in primary prevention
- Outcomes of intensive therapy in secondary‑free populations
Emphasizes translating risk reduction findings into routine clinical practice.
Lipid‑Lowering Therapeutics and PCSK9 Inhibition
Investigates the impact of novel PCSK9 inhibitors on lipid parameters and cardiovascular risk.
- Efficacy of PCSK9 blockade in achieving LDL‑C targets
- Safety profile of long‑term PCSK9 inhibition
- Combination of PCSK9 inhibitors with statin therapy
Supports optimized lipid management for patients with high baseline risk.
Vascular Event Outcomes and Revascularization
Analyzes the incidence of ischemia‑driven arterial revascularization alongside major adverse cardiac events.
- Predictors of revascularization in primary prevention
- Correlation between LDL‑C reduction and procedural need
- Long‑term follow‑up of revascularization rates
Provides insight into reducing procedural burden in high‑risk populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.